Valeant Pharma Securities Fraud Case Settled for $1.2 Billion
A securities case filed against Valeant Pharmaceuticals International, Inc. (now Bausch Health
Companies, Inc.) on behalf of both shareholders and bondholders has settled for $1.2 billion.
Monument’s Cynthia Jones served as plaintiffs’ expert for holders of the eleven Senior Notes
that will participate in the settlement, with total par value of $17.8 billion.